Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Chris Lange | Oct 25, 2019 at 10:05 AM EDT

Major Biotechs See Rising Tide in Short Interest

The October 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Oct 25, 2019 at 9:59 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Oct 23, 2019 at 10:25 AM EDT

Eli Lilly Just Couldn’t Get It Together in Q3

Eli Lilly shares retreated after it released mixed third-quarter financial results before the markets opened on Wednesday.

Chris Lange | Oct 22, 2019 at 12:05 PM EDT

Eton Pharma Wins Big With FDA Hypotension Treatment Approval

Eton Pharma shares jumped on Tuesday after the firm announced that the FDA has approved Biorphen for treatment of hypotension.

Chris Lange | Oct 22, 2019 at 10:20 AM EDT

Why Biogen’s Alzheimer’s Study Is Overshadowing Its Big Earnings Beat

Biogen released its third-quarter financial results and Alzheimer’s trial news before the markets opened on Tuesday.

Chris Lange | Oct 21, 2019 at 10:50 AM EDT

Big Step Forward in HER2-Positive Breast Cancer Trial

Seattle Genetics shares jumped on Monday after the firm announced positive results from its midstage breast cancer trial.

Jon C. Ogg | Oct 19, 2019 at 6:45 AM EDT

How Biotech and Big Pharma Have Upside Heading Into Earnings

Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.

Paul Ausick | Oct 17, 2019 at 12:27 PM EDT

Opioid Crisis Has Cost US Economy $631 Billion

Over the past four years, the economic cost of the opioid epidemic has cost the United States some $631 billion.…

Chris Lange | Oct 16, 2019 at 12:15 PM EDT

A Crucial Major Depressive Disorder Study Is About to Be Underway

Axsome Therapeutics shares made a handy gain on Wednesday after the firm announced that it has completed patient enrollment in…

Chris Lange | Oct 16, 2019 at 9:45 AM EDT

Are Shareholders Getting Enough in the Achillion Acquisition?

Achillion Pharmaceuticals shares skyrocketed on Wednesday morning on news that the firm would be acquired by Alexion Pharmaceuticals.

Chris Lange | Oct 15, 2019 at 12:35 PM EDT

Why This Neuromuscular Disorder Study Could Be the Next Big Thing

Reata Pharma shares jumped on Tuesday after the firm announced positive results from its midstage neuromuscular disorder drug trial.

Chris Lange | Oct 15, 2019 at 10:29 AM EDT

Johnson & Johnson Offers a Strong Start to Earnings Season

Johnson & Johnson reported better than expected quarterly results before the markets opened on Tuesday.

Chris Lange | Oct 15, 2019 at 10:10 AM EDT

UnitedHealth Helps Save the Dow With Q3 Earnings

UnitedHealth reported better than expected third-quarter financial results before the markets opened on Tuesday.

Chris Lange | Oct 14, 2019 at 1:00 PM EDT

What to Watch in the UnitedHealth Earnings Report Tuesday

UnitedHealth is set to release its third-quarter financial results before the markets open on Tuesday, and analysts are looking for…

Chris Lange | Oct 14, 2019 at 12:10 PM EDT

What to Expect When Johnson & Johnson Reports Tuesday

Johnson & Johnson is scheduled to report its most recent quarterly results before the markets open on Tuesday, and analysts'…

1 … 80 81 82 83 84 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Major Biotechs See Rising Tide in Short Interest

Short Sellers Can’t Make Up Their Minds on Big Pharma

Eli Lilly Just Couldn’t Get It Together in Q3

Eton Pharma Wins Big With FDA Hypotension Treatment Approval

Why Biogen’s Alzheimer’s Study Is Overshadowing Its Big Earnings Beat

Big Step Forward in HER2-Positive Breast Cancer Trial

How Biotech and Big Pharma Have Upside Heading Into Earnings

Opioid Crisis Has Cost US Economy $631 Billion

A Crucial Major Depressive Disorder Study Is About to Be Underway

Are Shareholders Getting Enough in the Achillion Acquisition?

Why This Neuromuscular Disorder Study Could Be the Next Big Thing

Johnson & Johnson Offers a Strong Start to Earnings Season

UnitedHealth Helps Save the Dow With Q3 Earnings

What to Watch in the UnitedHealth Earnings Report Tuesday

What to Expect When Johnson & Johnson Reports Tuesday

He Needs $30,000 for a Roof and Furnace at 69. A New Maine Law Could Help Him Borrow Without Making More of His Social Security Taxable.

Retirement Has Three Spending Phases. Most Budgets Only Cover the First One.

Ron Paul: Trump’s New Policy Is ‘As Dangerous to Liberty and Prosperity’ as Mamdani’s

He Needs $30,000 for a Roof and Furnace at 69. A New Maine Law Could Help Him Borrow Without Making More of His Social Security Taxable.

Retirement Has Three Spending Phases. Most Budgets Only Cover the First One.

He Needs $30,000 for a Roof and Furnace at 69. A New Maine Law Could Help Him Borrow Without Making More of His Social Security Taxable.

Retirement Has Three Spending Phases. Most Budgets Only Cover the First One.

Health and Healthcare Articles

All Health and Healthcare Articles

Major Biotechs See Rising Tide in Short Interest

Short Sellers Can’t Make Up Their Minds on Big Pharma

Eli Lilly Just Couldn’t Get It Together in Q3

Eton Pharma Wins Big With FDA Hypotension Treatment Approval

Why Biogen’s Alzheimer’s Study Is Overshadowing Its Big Earnings Beat

Big Step Forward in HER2-Positive Breast Cancer Trial

How Biotech and Big Pharma Have Upside Heading Into Earnings

Opioid Crisis Has Cost US Economy $631 Billion

A Crucial Major Depressive Disorder Study Is About to Be Underway

Are Shareholders Getting Enough in the Achillion Acquisition?

Why This Neuromuscular Disorder Study Could Be the Next Big Thing

Johnson & Johnson Offers a Strong Start to Earnings Season

UnitedHealth Helps Save the Dow With Q3 Earnings

What to Watch in the UnitedHealth Earnings Report Tuesday

What to Expect When Johnson & Johnson Reports Tuesday

He Needs $30,000 for a Roof and Furnace at 69. A New Maine Law Could Help Him Borrow Without Making More of His Social Security Taxable.

Retirement Has Three Spending Phases. Most Budgets Only Cover the First One.

Ron Paul: Trump’s New Policy Is ‘As Dangerous to Liberty and Prosperity’ as Mamdani’s

Featured Reads

He Needs $30,000 for a Roof and Furnace at 69. A New Maine Law Could Help Him Borrow Without Making More of His Social Security Taxable.

Retirement Has Three Spending Phases. Most Budgets Only Cover the First One.